1975
DOI: 10.1016/s0140-6736(75)91617-7
|View full text |Cite
|
Sign up to set email alerts
|

Jaundice Associated With Norethisterone-Acetate Treatment of Breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1976
1976
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…1 Intrahepatic cholestatic jaundice is well known and is due to estrogenic component of combined oral contraceptive medications. [2][3][4] Multiple case reports of oral contraceptive induced liver injury have been described in the literature. [2][3][4][5] Progestogens are usually not implicated in the process of cholestasis.…”
Section: Discussionmentioning
confidence: 99%
“…1 Intrahepatic cholestatic jaundice is well known and is due to estrogenic component of combined oral contraceptive medications. [2][3][4] Multiple case reports of oral contraceptive induced liver injury have been described in the literature. [2][3][4][5] Progestogens are usually not implicated in the process of cholestasis.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, even though there have been no reports of possible liver damage from OCs containing only low doses of gestagens, i.e. doses lower than those of the preparations considered in this report, there have been reports of cholestatic liver reactions from high-dose gestagen preparations (10 mg norethisterone acetate 3 4 times day-') in the treatment of breast cancer [20].…”
Section: Discussionmentioning
confidence: 78%